Tachibana Hirofumi
Forum Nutr. 2009;61:156-169. doi: 10.1159/000212748. Epub 2009 Apr 7.
For the past two decades, many researchers have been investigating the potential cancer-preventive and therapeutic effects of green tea. (-)-Epigallocatechin-3-O-gallate (EGCG) has been shown to be the most active and major polyphenolic compound from green tea. The mechanisms of action of EGCG have been extensively investigated. However, the mechanisms for the cancer-preventive activity of EGCG are not completely characterized and many features remain to be elucidated. Recently, we have identified the 67-kDa laminin receptor (67LR) as a cell surface EGCG receptor that confers EGCG responsiveness to many cancer cells at physiological concentrations. This article reviews some of the reported mechanisms and possible targets for the action of EGCG. We especially focus on the current understanding of the signaling pathway for physiologically relevant EGCG through the 67LR for cancer prevention. Our data shed new light on the molecular basis for the cancer-preventive activity of EGCG in vivo and helps in the design of new strategies to prevent cancer.
在过去二十年中,许多研究人员一直在研究绿茶潜在的防癌和治疗作用。(-)-表没食子儿茶素-3-没食子酸酯(EGCG)已被证明是绿茶中最具活性的主要多酚化合物。EGCG的作用机制已得到广泛研究。然而,EGCG防癌活性的机制尚未完全明确,许多特性仍有待阐明。最近,我们已确定67kDa层粘连蛋白受体(67LR)为细胞表面EGCG受体,其在生理浓度下赋予许多癌细胞对EGCG的反应性。本文综述了一些已报道的EGCG作用机制和可能的作用靶点。我们特别关注目前对通过67LR实现生理相关EGCG防癌信号通路的理解。我们的数据为EGCG体内防癌活性的分子基础提供了新线索,并有助于设计预防癌症的新策略。